Pharmaceutical Medical Malpracitce Archives - Page 6 of 18

Medical Director Of Maryland Pain Management Practice Pleads Guilty To Accepting Kickbacks

June 26, 2021

The U.S. Attorney for the District of Maryland announced on June 10, 2021 that 65-year-old Howard Hoffberg, M.D. (“Hoffman”) pleaded guilty on June 9, 2021 to the federal charge of conspiracy to violate the anti-kickback statutes in connection with a scheme to accept payments from a phar[...]

Federal Appellate Court Applies Preemption In Reversing Verdict Against Pharmaceutical Company

March 9, 2021

The United States Court of Appeals for the Fourth Circuit (“Federal Appellate Court”) held in its published opinion dated January 6, 2020: “Boehringer [Boehringer Ingelheim Pharmaceuticals, Inc.] did not have “newly acquired information” regarding an optimal Pradaxa blood conce[...]

Mississippi Pharmacy Owner Sentenced To 18-Year Prison Sentence For His Part In $287M Health Care Fraud Scheme

February 7, 2021

On January 15, 2021, the U. S. Department of Justice announced that a 54-year-old Mississippi businessman who co-owned numerous compounding pharmacies and pharmaceutical distributors was sentenced to 18 years in prison on his guilty plea to one count of conspiracy to commit health care fraud and one[...]

Federal Appellate Court Applies Georgia’s Learned Intermediary Doctrine To Deny Stroke Victim’s Recovery

January 13, 2021

The United States Court of Appeals for the Eleventh Circuit (“Federal Appellate Court”) held in its published opinion dated December 22, 2020, “This tragic case began when Karen Hubbard suffered a catastrophic stroke. The stroke left her paralyzed and her cognitive functions severe[...]

Biogen To Pay $22M To Settle Illegal Kickbacks Allegations

January 9, 2021

The U.S. Attorney’s Office for the District of Massachusetts announced on December 17, 2020 that Cambridge-based pharmaceutical company Biogen Inc. (Biogen) has agreed to pay $22 million to resolve allegations that it violated the False Claims Act by illegally using two foundations, Chronic D[...]

Federal Appellate Court Affirms Podiatrist’s Conviction For His Involvement In Illegal Kickback Scheme

December 15, 2020

On November 24, 2020, the U.S. Court of Appeals for the Eleventh Circuit affirmed a Georgia podiatrist’s conviction and sentence for his alleged role in an illegal kickback scheme involving TRICARE, a federal program for members of the military and their families. The Defendant, Dr. Alap Sha[...]

Drug Company Issues Recall Of Certain Lots Of Erectile Dysfunction Drug And Depression Drug Due To “Product Mix-Up”

December 11, 2020

AvKARE, Pulaski, TN announced on December 9, 2020 that it is voluntarily recalling one lot of Sildenafil 100 mg tablets and one lot of Trazodone 100mg tablets to the consumer level. These products have been recalled “due to a product mix-up of the listed two separate products inadvertently pac[...]

Gilead Will Pay $97M To Resolve Alleged False Claims Act Liability For Illegal Kickbacks

November 30, 2020

The U.S. Department of Justice announced on September 23, 2020 that the pharmaceutical company Gilead Sciences, Inc. (“Gilead”), which is based in Foster City, California, has agreed to pay $97 million to resolve claims that it violated the False Claims Act by illegally using a foundatio[...]

U.S. Government Alleges Teva Pharmaceuticals Illegally Paid Medicare Co-Pays For Its MS Drug

September 23, 2020

The United States government announced on August 18, 2020 that it has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. (“Teva”), alleging that they illegally paid the Medicare co-pays for their multiple sclerosis (“MS”) drug,[...]

Missouri Appellate Court Reduces $4.69 Billion Talc Verdict Against Johnson & Johnson By One-Half

June 30, 2020

The Talc Allegations The twenty-two plaintiffs alleged that they developed ovarian cancer after continued use of two of the defendants’ talc products: Johnson’s Baby Powder (“Johnson’s Baby Powder”) and Shower to Shower, including any variation, modification, or extension such as Shower to[...]

Study Found Top 1% Of Opioid Prescribers In U.S. Responsible For 49% Of Opioid Prescriptions

June 25, 2020

A study entitled “Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study” published on January 29, 2020 in the British medical journal BMJ reported: “In 2017, the top 1% of providers accounted for 49% of all opioid dose[...]

FTC Chairman Issues Statement Regarding Competition For Biosimilars

May 27, 2020

On March 9, 2020, the Chairman of the Federal Trade Commission provided opening remarks at the FDA/FTC Workshop on a Competitive Marketplace for Biosimilars in Silver Spring, Maryland, which workshop is a collaboration between the Federal Trade Commission and the Food & Drug Administration to p[...]

« 1 2 3 4 5 6 7 8 9 10 11 … 18 »

Category: Pharmaceutical Medical Malpracitce